Optimization and validation of RP-HPLC method for simultaneous estimation of palbociclib and letrozole.

about

Optimization and validation of RP-HPLC method for simultaneous estimation of palbociclib and letrozole.

Item

http://www.wikidata.org/entity/Q48239334

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Optimization and validation of ...... of palbociclib and letrozole.

@en

Optimization and validation of ...... of palbociclib and letrozole.

@nl

type

Item

label

Optimization and validation of ...... of palbociclib and letrozole.

@en

Optimization and validation of ...... of palbociclib and letrozole.

@nl

prefLabel

Optimization and validation of ...... of palbociclib and letrozole.

@en

Optimization and validation of ...... of palbociclib and letrozole.

@nl

P1476

Optimization and validation of ...... of palbociclib and letrozole.

@en

P2093

Vijay Salunkhe

http://www.w3.org/2001/XMLSchema#string

Yuvraj Dange

http://www.w3.org/2001/XMLSchema#string

P2860

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

Palbociclib (PD 0332991) : targeting the cell cycle machinery in breast cancer.

Development of a high-performance liquid chromatographic method for determination of letrozole in wistar rat serum and its application in pharmacokinetic studies

Phase I study of palbociclib, a cyclin-dependent kinase 4/6 inhibitor, in Japanese patients

Reverse phase high performance liquid chromatographic method for the analysis of letrozole in pharmaceutical dosage forms.

Development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study.

Identification of the aromatase inhibitor letrozole in urine by gas chromatography/mass spectrometry.

Stability-indicating liquid chromatographic method for the determination of Letrozole in pharmaceutical formulations.

High-performance liquid chromatography of the aromatase inhibitor, letrozole, and its metabolite in biological fluids with automated liquid-solid extraction and fluorescence detection.

P304

187-194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/15376516.2017.1388458

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Somnath Bhinge

P577

2017-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28980851

http://www.w3.org/2001/XMLSchema#string